Coexistence of hepatopulmonary syndrome and portopulmonary hypertension before a liver transplantation: a case report and review of the literature
Liver transplantation remains the treatment of choice for hepatopulmonary syndrome (HPS) with severe hypoxemia, but portopulmonary hypertension (PoPH) has traditionally been viewed as a contraindication to liver transplantation owing to its frequent posttransplant deterioration. We describe here the sequential presence of both pulmonary vascular disorders in a cirrhotic patient in the pretransplant period. Liver transplantation was made possible following effective management of pulmonary hypertension, with favorable outcome 3 years post-liver transplantation. Finally, our case report and literature review suggest that the coexistence of HPS and PoPH in patients with advanced liver disease could be more common than previously recognized.
Authors
- Sophie Vendeville
- Thierry Thévenot (ORCID: https://orcid.org/0000-0003-3974-2784)
- Valentin Vacelet
- Djamal Tazibt
Institutions
- Centre Hospitalier Universitaire de Besançon (FR)
- CHU Dijon Bourgogne (FR)
Publication Details
- Journal
- European Journal of Gastroenterology & Hepatology
- Published
- 2026-02-23
- DOI
- https://doi.org/10.1097/meg.0000000000003167
- Primary Topic
- Liver Disease and Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00